51.05
+0.15
+(0.29%)
As of 10:02:41 AM GMT+2. Market Open.
Breakdown
TTM
11/30/2024
11/30/2023
11/30/2022
11/30/2021
Total Revenue
2,089,819
2,035,903
1,990,486
1,817,094
1,498,007
Cost of Revenue
1,484,897
1,428,138
1,393,172
1,270,282
1,051,685
Gross Profit
604,922
607,765
597,314
546,812
446,322
Operating Expense
388,094
374,170
367,845
353,100
256,934
Operating Income
216,828
233,595
229,469
193,712
189,388
Net Non Operating Interest Income Expense
-79,550
-50,655
-45,962
-28,502
-19,576
Pretax Income
101,151
146,813
167,429
140,811
127,865
Tax Provision
19,748
34,496
47,344
38,620
40,624
Net Income Common Stockholders
78,699
109,720
116,126
96,120
83,788
Diluted NI Available to Com Stockholders
78,699
109,720
116,126
96,120
83,788
Basic EPS
2.28
3.18
3.48
3.06
2.67
Diluted EPS
2.28
3.18
3.48
3.06
2.67
Basic Average Shares
34,540
34,540
33,336
31,400
31,400
Diluted Average Shares
34,540
34,540
33,336
31,400
31,400
Total Operating Income as Reported
180,701
197,468
213,391
169,313
147,441
Total Expenses
1,872,991
1,802,308
1,761,017
1,623,382
1,308,619
Net Income from Continuing & Discontinued Operation
78,699
109,720
116,126
96,120
83,788
Normalized Income
106,633.27
136,273.92
126,516.05
113,483.02
111,996.20
Interest Income
5,214
4,906
3,802
1,984
1,326
Interest Expense
89,759
60,625
50,435
27,955
20,702
Net Interest Income
-79,550
-50,655
-45,962
-28,502
-19,576
EBIT
190,910
207,438
217,864
168,766
148,567
EBITDA
409,197
405,970
403,890
340,321
293,926
Reconciled Cost of Revenue
1,484,897
1,428,138
1,393,172
1,270,282
1,051,685
Reconciled Depreciation
218,287
198,532
186,026
171,555
145,359
Net Income from Continuing Operation Net Minority Interest
78,699
109,720
116,126
96,120
83,788
Total Unusual Items Excluding Goodwill
-34,711
-34,711
-14,491
-23,916
-41,361
Total Unusual Items
-34,711
-34,711
-14,491
-23,916
-41,361
Normalized EBITDA
443,908
440,681
418,381
364,237
335,287
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-6,776.73
-8,157.09
-4,100.95
-6,552.98
-13,152.80
11/30/2021 - 6/11/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
5889.T JAPAN EYEWEAR HOLDINGS CO LTD
1,992.00
-0.25%
HGYMF Hogy Medical Co.,Ltd.
24.34
0.00%
7730.T Mani, Inc.
1,065.00
+0.09%
TECN.SW Tecan Group AG
139.70
-2.92%
7716.T Nakanishi Inc.
1,778.00
-3.26%
7747.T Asahi Intecc Co., Ltd.
2,157.50
-0.92%
SRT0.F Sartorius Aktiengesellschaft
42.40
+1.92%
SKAN.SW SKAN Group AG
62.00
-0.48%
AMS.L Advanced Medical Solutions Group plc
186.12
-1.00%
SRT3.F Sartorius Aktiengesellschaft
207.00
-1.62%